Suddoc Profile Banner
Sukrit Sud MD,DM Profile
Sukrit Sud MD,DM

@Suddoc

Followers
1K
Following
2K
Media
137
Statuses
1K

Gastroenterologist, Hepatologist, Interventional endoscopist @Medanta the medicity, Spl int:Endosono/3rd space/tumour resection

New Delhi
Joined March 2011
Don't wanna be here? Send us removal request.
@elonmusk
Elon Musk
2 months
Cancel Netflix for the health of your kids
@cb_doge
DogeDesigner
2 months
Protect your kids. Cancel Netflix.
37K
150K
990K
@Brunorm84
Bruno Ramos-Molina, PhD
9 months
Incretin triple agonist retatrutide (LY3437943) alleviates #obesity-associated #cancer progression | npj Metabolic Health and Disease @Nature_NPJ
Tweet card summary image
nature.com
npj Metabolic Health and Disease - Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
0
9
19
@drradhikachavan
@drradhikachavan, MD, DNB, FISG, FASGE
1 year
Sharing our multi-center experience on "Endoscopic ultrasound-guided drainage of the gallbladder" published in the @IJG_Journal. EUS-GBD is a safe & effective modality for treating acute cholecystitis and distal malignant biliary obstruction. https://t.co/at3XMIk47W
2
14
67
@IBDGastroDocSg
Malcolm Tan
2 years
ADMIT-ASC index for ASUC. Score of ≥3 was 84% predictive of steroid failure - CRP ≥100mg/L (1 point) - albumin ≤25g/L (1 point) - UCEIS ≥4 (1 point) or ≥7 (2 points) Will these pts benefit from early 'salvage' therapy instead of waiting till D3? https://t.co/iIBrNl3Y0e
1
20
55
@charlie_lees
Charlie Lees
2 years
10 tips to improve outcomes for your IBD patients in 2023 1) ADOPT early effective therapy in Crohn’s disease This is best way to stop the disease from progressing. 2) Manage flares expediently in UC with advanced therapies Stopping flares quickly is good for patients and
6
29
104
@Suddoc
Sukrit Sud MD,DM
2 years
0
1
1
@Suddoc
Sukrit Sud MD,DM
2 years
The IBD school @ DMC Ludhiana was a resounding success. Great discussions across the spectrum of IBD cases between faculty and residents from across India
2
3
23
@Nareshbhat14
Naresh bhat
2 years
CCF India organised IBD school for GI fellows. The best part is seeing the emergence of younger consultants as faculty . Glad that Ajit Sood took the initiative ⁦@CCF_IN⁩ ⁦@Kayalvn⁩ ⁦@drkrpradeep⁩ ⁦@drvishal82⁩ ⁦⁩⁦@vandana_midha
1
7
39
@Suddoc
Sukrit Sud MD,DM
2 years
Register now for EPL 2023 by Medanta at Andaaz Hyatt New Delhi Sep 30-Oct 2nd ... Stellar international faculty and legends of Indian GI endoscopy all under one roof #GITwitter #EPL2023 #medanta #advancedendoscopy
0
0
10
@Suddoc
Sukrit Sud MD,DM
2 years
Register now for the EPL 2023...Registrations open for Hands-on workshop on multiple aspects of advanced endoscopy #EPL2023 #GITwitter
0
2
10
@gnioannou
George Ioannou
2 years
Welcome to MELD 3.0❗️ OPTN adopted this improved version of MELD for liver transplant prioritization: 1⃣Adds 1-2 extra points for women vs. men to account for creatinine sex differences 2⃣Includes albumin (+ Bili, Cr, INR, Na as before) Use it here: https://t.co/h2nN1CrWeG
1
61
195
@Rob__Brierley
Rob Brierley
2 years
52 week data from LIBERT EoE TREET 👉Improvements in histological, symptomatic, endoscopic & molecular features of #EosinophilicOesophagitis seen after 24 wks of weekly dupilumab treatment maintained or continued to improve to wk 52 #GITwitter #EoE
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
2 years
New research - Safety and efficacy of dupilumab for up to 52 weeks in adults & adolescents with eosinophilic oesophagitis - further results from LIBERTY EoE TREET https://t.co/uUruvKmrJ2 #EoE #GITwitter
0
4
12
@Suddoc
Sukrit Sud MD,DM
2 years
Our review article on the very controversial EUS guided liver biopsy @medanta #GITwitter
1
0
5
@DocsExplainFM
DOCTORS EXPLAIN
2 years
Prevention Tips 💯 Maintain a healthy weight 💯 Stop smoking 💯 Elevate the head of your bed 💯 Start on your left side 💯 Don't lie down after a meal 💯 Eat food slowly and chew thoroughly 💯 Avoid foods and drinks that trigger reflux 💯 Avoid tight-fitting clothing #acidreflux
0
2
5
@drdeepakmadhu
Deepak Madhu
2 years
🌟Follow up of patients with gastric atrophy and intestinal metaplasia🌟 ✳️ESGE- MAPS II Guideline✳️ #GITwitter #MedTwitter @bentharian @AgnihotriGI @BabuPMohan2 @DrLakhtakia @drmohanjr @ZaheerNabi8 @Suddoc https://t.co/WwAXPaurMd
0
24
45
@Suddoc
Sukrit Sud MD,DM
2 years
Save the date... It's going to be an exciting endoscopy extravaganza #GITwitter #advancedendoscopy #thirdspaceendoscopy #ERCP #EUS
1
4
23
@JeanFredericCo1
Jean-Frederic Colombel
2 years
Ustekinumab works often fast but a significant % of patients need first sc for induction. Evolution of symptoms after ustekinumab induction therapy in patients with Crohn's disease.
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
gov numbers, NCT01369329, NCT01369342, and NCT01369355.
0
12
48
@massimoiava
massimo iavarone
2 years
CAMARO open label RCT study for #autoimmune hepatitis 1. #mycophenolate vs #azatioprine 2. 31 vs 39 pts 3. ✅️ Primary outcome: % clinical remission reached: 55% vs 29% 4.🟰 cumulative dose of #prednisolone 5. NO severe adverse events in MMF arm 6. 🟰 in QoL #EASLCongress
0
18
33
@RajivJalan1
Prof Rajiv Jalan
2 years
https://t.co/KQorIDMRcj @JHepatology @ef_clif @UK_CLIF @ruben_hernaez @_ILTS_ @VinaySundaramMD ✅SALT-M score provides online calculator to estimate risk of death following liver transplantation for ACLF patients🔆🔆🔆The score is named after the inspirational late Vinay Sundaram
3
25
51